Skip to content

Dietary Macronutrient Manipulation and Substrate Oxidation During Exercise

The Effect of Dietary Macronutrient Manipulation and Glycogen Depleting Exercise on Substrate Oxidation at Rest and During Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02605291
Enrollment
13
Registered
2015-11-16
Start date
2016-01-31
Completion date
2017-06-30
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Manipulation

Brief summary

This study will investigate the effect of dietary macronutrient manipulation on glycogen (stored carbohydrate) levels in the muscle and substrate oxidation during exercise. The investigators will investigate the hypothesis that manipulating the macronutrient content of the diet will alter the levels of glycogen in the muscle and, in turn, substrate oxidation during exercise.

Detailed description

One way to help reduce body fat is to expend more energy from the oxidation of fat as a fuel. Exercise is one way to increase fat oxidation. The extent to which exercise facilitates the use of fat as a fuel may be influenced by an individual's dietary intake. This study aims to establish the effect of dietary macronutrient manipulation on muscle glycogen levels and substrate oxidation during exercise. Participants will undertake three separate trial periods. During each trial period participants will consume a diet containing different macronutrient compositions. For each of the trials the investigators will assess how the macronutrient composition of the diet affects muscle glycogen level and substrate oxidation during exercise.

Interventions

OTHERDiet with a different macronutrient content A

A diet with altered macronutrient content will be provided to participants on days 4-6 of experimental arm 1.

OTHERDiet with a different macronutrient content B

A diet with a different macronutrient content compared to arm 1 will be provided to participants on days 4-6 of experimental arm 2.

OTHERDiet with a different macronutrient content C

A diet with a different macronutrient content compared to arms 1 and 2 will be provided to participants on days 4-6 of experimental arm 3.

OTHERInterval treadmill running exercise

Participants will perform interval treadmill running exercise on days 4 and 5 of all experimental arms.

OTHERSteady state treadmill running exercise

Participants will perform steady state treadmill running exercise on day 7 of all experimental arms.

Sponsors

Lucozade Ribena Suntory
CollaboratorINDUSTRY
University of Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Good general health * Non-smoking - currently and for the past 5 years * Fitness - V̇O2max 40-60 ml/kg/min * Body mass index (20-25 kg/m2)

Exclusion criteria

* Known or suspected intolerance to the dietary interventions or their stated ingredients. * Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit. * Previous participation in this study. * Recent history (within the last year) of alcohol or other substance abuse. * An employee of the sponsor or the study site or members of their immediate family. * Abnormal / extreme habitual dietary practice / intake * Recent (≤3 months) dietary practice that may be deemed as low and/or high in macronutrients will be excluded. * The taking of any prescribed medication

Design outcomes

Primary

MeasureTime frameDescription
Muscle glycogen concentration after dietary macronutrient manipulationDay 7 of all experimental armsMuscle glycogen concentration will be measured after the dietary macronutrient manipulation intervention.

Secondary

MeasureTime frameDescription
Rate of fat oxidation at rest (g/min)For 20 min on Day 7 of all experimental armsWhole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of fat oxidation at rest (g/min).
Rate of fat oxidation during exercise (g/min)During 60 min of exercise on day 7 of all experimental armsWhole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) during exercise will be measured using indirect calorimetry to calculate the rate of fat oxidation during exercise (g/min).
Rate of carbohydrate oxidation during exercise (g/min)During 60 min of exercise on day 7 of all experimental armsWhole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) during exercise will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation during exercise (g/min).
Rate of carbohydrate oxidation at rest (g/min)For 20 min on Day 7 of all experimental armsWhole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation at rest (g/min).
Blood insulin concentrationAt 0, 20, 40 and 60min into exercise on day 7 of all experimental armsBlood insulin concentration will be assessed in blood samples taken during exercise.
Blood fatty acid concentrationAt 0, 20, 40 and 60min into exercise on day 7 of all experimental armsBlood fatty acid concentration will be assessed in blood samples taken during exercise.
Change in intramuscular triglyceride (IMTG) content after exerciseIMTG content measured just before and immediately after 60min of exercise on Day 7 of all experimental armsIMTG utilisation during exercise (or change in IMTG content pre-post exercise) will be measured by comparing the IMTG content before and after exercise.
Blood glucose concentrationAt 0, 20, 40 and 60min into exercise on day 7 of all experimental arms.Blood glucose concentration will be assessed in blood samples taken during exercise.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026